Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles

Udaya S. Toti, Bharath R. Guru, Mirabela Hali, Christopher M. McPharlin, Susan M. Wykes, Jayanth Panyam, Judith A. Whittum-Hudson

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Chlamydia trachomatis and Chlamydia pneumoniae are intracellular bacterial pathogens that have been shown to cause, or are strongly associated with, diverse chronic diseases. Persistent infections by both organisms are refractory to antibiotic therapy. The lack of therapeutic efficacy results from the attenuated metabolic rate of persistently infecting chlamydiae in combination with the modest intracellular drug concentrations achievable by normal delivery of antibiotics to the inclusions within which chlamydiae reside in the host cell cytoplasm. In this research, we evaluated whether nanoparticles formulated using the biodegradable poly(d-l-lactide-co-glycolide) (PLGA) polymer can enhance the delivery of antibiotics to the chlamydial inclusion complexes. We initially studied the trafficking of PLGA nanoparticles in Chlamydia-infected cells. We then evaluated nanoparticles for the delivery of antibiotics to the inclusions. Intracellular trafficking studies show that PLGA nanoparticles efficiently concentrate in inclusions in both acutely and persistently infected cells. Further, encapsulation of rifampin and azithromycin antibiotics in PLGA nanoparticles enhanced the effectiveness of the antibiotics in reducing microbial burden. Combination of rifampin and azithromycin was more effective than the individual drugs. Overall, our studies show that PLGA nanoparticles can be effective carriers for targeted delivery of antibiotics to intracellular chlamydial infections.

Original languageEnglish
Pages (from-to)6606-6613
Number of pages8
JournalBiomaterials
Volume32
Issue number27
DOIs
Publication statusPublished - 01-09-2011

Fingerprint

Antibiotics
Nanoparticles
Anti-Bacterial Agents
Infection
Chlamydia
Azithromycin
Rifampin
Chlamydophila pneumoniae
Chlamydia trachomatis
Pathogens
polylactic acid-polyglycolic acid copolymer
Encapsulation
Pharmaceutical Preparations
Refractory materials
Polymers
Cytoplasm
Chronic Disease
Therapeutics
Research

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Toti, U. S., Guru, B. R., Hali, M., McPharlin, C. M., Wykes, S. M., Panyam, J., & Whittum-Hudson, J. A. (2011). Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials, 32(27), 6606-6613. https://doi.org/10.1016/j.biomaterials.2011.05.038
Toti, Udaya S. ; Guru, Bharath R. ; Hali, Mirabela ; McPharlin, Christopher M. ; Wykes, Susan M. ; Panyam, Jayanth ; Whittum-Hudson, Judith A. / Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. In: Biomaterials. 2011 ; Vol. 32, No. 27. pp. 6606-6613.
@article{23f617f146b1453a9f11ceb27bdac52f,
title = "Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles",
abstract = "Chlamydia trachomatis and Chlamydia pneumoniae are intracellular bacterial pathogens that have been shown to cause, or are strongly associated with, diverse chronic diseases. Persistent infections by both organisms are refractory to antibiotic therapy. The lack of therapeutic efficacy results from the attenuated metabolic rate of persistently infecting chlamydiae in combination with the modest intracellular drug concentrations achievable by normal delivery of antibiotics to the inclusions within which chlamydiae reside in the host cell cytoplasm. In this research, we evaluated whether nanoparticles formulated using the biodegradable poly(d-l-lactide-co-glycolide) (PLGA) polymer can enhance the delivery of antibiotics to the chlamydial inclusion complexes. We initially studied the trafficking of PLGA nanoparticles in Chlamydia-infected cells. We then evaluated nanoparticles for the delivery of antibiotics to the inclusions. Intracellular trafficking studies show that PLGA nanoparticles efficiently concentrate in inclusions in both acutely and persistently infected cells. Further, encapsulation of rifampin and azithromycin antibiotics in PLGA nanoparticles enhanced the effectiveness of the antibiotics in reducing microbial burden. Combination of rifampin and azithromycin was more effective than the individual drugs. Overall, our studies show that PLGA nanoparticles can be effective carriers for targeted delivery of antibiotics to intracellular chlamydial infections.",
author = "Toti, {Udaya S.} and Guru, {Bharath R.} and Mirabela Hali and McPharlin, {Christopher M.} and Wykes, {Susan M.} and Jayanth Panyam and Whittum-Hudson, {Judith A.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.biomaterials.2011.05.038",
language = "English",
volume = "32",
pages = "6606--6613",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "27",

}

Toti, US, Guru, BR, Hali, M, McPharlin, CM, Wykes, SM, Panyam, J & Whittum-Hudson, JA 2011, 'Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles', Biomaterials, vol. 32, no. 27, pp. 6606-6613. https://doi.org/10.1016/j.biomaterials.2011.05.038

Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. / Toti, Udaya S.; Guru, Bharath R.; Hali, Mirabela; McPharlin, Christopher M.; Wykes, Susan M.; Panyam, Jayanth; Whittum-Hudson, Judith A.

In: Biomaterials, Vol. 32, No. 27, 01.09.2011, p. 6606-6613.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles

AU - Toti, Udaya S.

AU - Guru, Bharath R.

AU - Hali, Mirabela

AU - McPharlin, Christopher M.

AU - Wykes, Susan M.

AU - Panyam, Jayanth

AU - Whittum-Hudson, Judith A.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Chlamydia trachomatis and Chlamydia pneumoniae are intracellular bacterial pathogens that have been shown to cause, or are strongly associated with, diverse chronic diseases. Persistent infections by both organisms are refractory to antibiotic therapy. The lack of therapeutic efficacy results from the attenuated metabolic rate of persistently infecting chlamydiae in combination with the modest intracellular drug concentrations achievable by normal delivery of antibiotics to the inclusions within which chlamydiae reside in the host cell cytoplasm. In this research, we evaluated whether nanoparticles formulated using the biodegradable poly(d-l-lactide-co-glycolide) (PLGA) polymer can enhance the delivery of antibiotics to the chlamydial inclusion complexes. We initially studied the trafficking of PLGA nanoparticles in Chlamydia-infected cells. We then evaluated nanoparticles for the delivery of antibiotics to the inclusions. Intracellular trafficking studies show that PLGA nanoparticles efficiently concentrate in inclusions in both acutely and persistently infected cells. Further, encapsulation of rifampin and azithromycin antibiotics in PLGA nanoparticles enhanced the effectiveness of the antibiotics in reducing microbial burden. Combination of rifampin and azithromycin was more effective than the individual drugs. Overall, our studies show that PLGA nanoparticles can be effective carriers for targeted delivery of antibiotics to intracellular chlamydial infections.

AB - Chlamydia trachomatis and Chlamydia pneumoniae are intracellular bacterial pathogens that have been shown to cause, or are strongly associated with, diverse chronic diseases. Persistent infections by both organisms are refractory to antibiotic therapy. The lack of therapeutic efficacy results from the attenuated metabolic rate of persistently infecting chlamydiae in combination with the modest intracellular drug concentrations achievable by normal delivery of antibiotics to the inclusions within which chlamydiae reside in the host cell cytoplasm. In this research, we evaluated whether nanoparticles formulated using the biodegradable poly(d-l-lactide-co-glycolide) (PLGA) polymer can enhance the delivery of antibiotics to the chlamydial inclusion complexes. We initially studied the trafficking of PLGA nanoparticles in Chlamydia-infected cells. We then evaluated nanoparticles for the delivery of antibiotics to the inclusions. Intracellular trafficking studies show that PLGA nanoparticles efficiently concentrate in inclusions in both acutely and persistently infected cells. Further, encapsulation of rifampin and azithromycin antibiotics in PLGA nanoparticles enhanced the effectiveness of the antibiotics in reducing microbial burden. Combination of rifampin and azithromycin was more effective than the individual drugs. Overall, our studies show that PLGA nanoparticles can be effective carriers for targeted delivery of antibiotics to intracellular chlamydial infections.

UR - http://www.scopus.com/inward/record.url?scp=79960078409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960078409&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2011.05.038

DO - 10.1016/j.biomaterials.2011.05.038

M3 - Article

VL - 32

SP - 6606

EP - 6613

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 27

ER -